A small amount of GENTAMICIN OINTMENT or CREAM should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of GENTAMICIN OINTMENT or CREAM to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infect...
Each gram of GENTAMICIN CREAM contains gentamicin sulfate
equivalent to 1 mg of gentamicin base in a cream base of: methylparaben,
butylparaben, stearic acid, cerasynt PA (propylene glycol monostearate),
isopropyl myristate, propylene glycol, polysorbate 40, sorbitol solution and
water. Each gram of GENTAMICIN OINTMENT contains gentamicin sulfate equivalent
to 1 mg of gentamicin base in a base of: Light Mineral Oil and White Petrolatum,
with 0.5 mg methylparaben and 0.1 mg propylparaben as preservatives.
CLINICAL PHARMACOLOGY
CLINICAL PHARMACOLOGY SECTION
GENTAMICIN, a wide spectrum antibiotic provides highly effective
topical treatment in primary and secondary bacterial infections of the skin.
This product may clear infections that have not responded to other topical
antibiotic agents. In impetigo contagiosa and other primary skin infections,
treatment with a small amount of GENTAMICIN OINTMENT AND CREAM three to four
times daily usually clears the lesions promptly. In secondary skin infections,
the product facilitates the treatment of the underlying dermatosis by
controlling the infection. Bacteria susceptible to the action of GENTAMICIN
include sensitive strains of streptococci (group A beta-hemolytic,
alpha-hemolytic), Staphylococcus aureus (coagulase
positive, coagulase negative, and some penicillinase-producing strains), and the
gram-negative bacteria, Pseudomonas aeruginosa, Aerobacter
aerogens, Escherichia coli, Proteus vulgaris and Klebsiella
pneumoniae.
INDICATIONS AND USAGE
INDICATIONS & USAGE SECTION
Primary skin infections: Impetigo contagiosa, superficial
folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum.
Secondary skin infections: Infectious eczematoid dermatitis, pustular acne,
pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis
(including poison ivy), infected excoriations, and bacterial superinfections of
fungal or viral infections. NOTE: Gentamicin is a bactericidal agent that is not
effective against viruses or fungi in skin infections. It is useful in the
treatment of infected skin cysts and certain other skin abscesses when preceded
by incision and drainage to permit adequate contact between the antibiotic and
the infecting bacteria. Good results have been obtained in the treatment of
infected stasis and other skin ulcers, infected superficial burns, paronychia,
infected insect bites and stings, infected lacerations and abrasions and wounds
from minor surgery. Patients sensitive to neomycin can be treated with
GENTAMICIN, although regular observation of patients sensitive to topical
antibiotics is advisable when such patients are treated with any topical
antibiotic. GENTAMICIN CREAM is recommended for wet, oozing primary infections,
and greasy, secondary infections, such as pustular acne or infected seborrheic
dermatitis, and where a water washable cream preparation is desired. GENTAMICIN
OINTMENT helps retain moisture and has been useful in infection on dry
eczematous or psoriatic skin. GENTAMICIN CREAM and OINTMENT have been used
successfully in infants over one year of age as well as in adults and
children.
CONTRAINDICATIONS
CONTRAINDICATIONS SECTION
This product, GENTAMICIN OINTMENT AND CREAM is contraindicated in
individuals with a history of sensitivity reactions to any of its
components.
PRECAUTIONS
PRECAUTIONS SECTION
Use of topical antibiotics occasionally allows overgrowth of
nonsusceptible organisms, including fungi. If this occurs, or if irritation,
sensitization, or superinfection develops, treatment with GENTAMICIN should be
discontinued and appropriate therapy instituted.
ADVERSE REACTIONS
ADVERSE REACTIONS SECTION
In patients with dermatoses treated with GENTAMICIN, irritation
(erythema and pruritus) that did not usually require discontinuance of treatment
has been reported in a small percentage of cases. There was no evidence of
irritation or sensitization, however, in any of these patients patch-tested
subsequently with gentamicin on normal skin. Possible photosensitization has
been reported in several patients but could not be elicited in these patients by
reapplication of gentamicin followed by exposure to ultraviolet radiation.
DOSAGE AND ADMINISTRATION
DOSAGE & ADMINISTRATION SECTION
A small amount of GENTAMICIN OINTMENT or CREAM should be applied
gently to lesions three to four times a day. The area treated may be covered
with a gauze dressing if desired. In impetigo contagiosa, the crusts should be
removed before application of GENTAMICIN OINTMENT or CREAM to permit maximum
contact between the antibiotic and the infection. Care should be exercised to
avoid further contamination of the infected skin. Infected stasis ulcers have
responded well to GENTAMICIN under gelatin packing.
HOW SUPPLIED
HOW SUPPLIED SECTION
GENTAMICIN CREAM is supplied in
15 gram tube
NDC 54868-3524-0
30 gram tube
NDC 54868-3524-1
Store at controlled room temperature 15°-30°C (59°-86°F).
MANUFACTURED BY PERRIGO BRONX, NY 10457
1C800 RC J2
Relabeling of "Additional" barcode label by: Physicians Total Care, Inc. Tulsa, OK 74146
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.